| Tumor growth need not be driven by rare cancer stem cells PN Kelly, A Dakic, JM Adams, SL Nutt, A Strasser Science 317 (5836), 337-337, 2007 | 1038 | 2007 |
| Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo SH Naik, P Sathe, HY Park, D Metcalf, AI Proietto, A Dakic, S Carotta, ... Nature immunology 8 (11), 1217-1226, 2007 | 1030 | 2007 |
| Cutting edge: generation of splenic CD8+ and CD8− dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures SH Naik, AI Proietto, NS Wilson, A Dakic, P Schnorrer, M Fuchsberger, ... The Journal of Immunology 174 (11), 6592-6597, 2005 | 631 | 2005 |
| PU. 1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis A Dakic, D Metcalf, L Di Rago, S Mifsud, L Wu, SL Nutt The Journal of experimental medicine 201 (9), 1487-1502, 2005 | 357 | 2005 |
| The transcription factor PU. 1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner S Carotta, A Dakic, A D'amico, SHM Pang, KT Greig, SL Nutt, L Wu Immunity 32 (5), 628-641, 2010 | 324 | 2010 |
| Stage-specific control of early B cell development by the transcription factor Ikaros TA Schwickert, H Tagoh, S Gültekin, A Dakic, E Axelsson, M Minnich, ... Nature immunology 15 (3), 283-293, 2014 | 227 | 2014 |
| Development of the dendritic cell system during mouse ontogeny A Dakic, Q Shao, A D’Amico, M O’Keeffe, W Chen, K Shortman, L Wu The Journal of Immunology 172 (2), 1018-1027, 2004 | 187 | 2004 |
| Identification of Pax5 target genes in early B cell differentiation C Pridans, ML Holmes, M Polli, JM Wettenhall, A Dakic, LM Corcoran, ... The Journal of Immunology 180 (3), 1719-1728, 2008 | 173 | 2008 |
| Response to comment on" tumor growth need not be driven by rare cancer stem cells" JM Adams, PN Kelly, A Dakic, SL Nutt, A Strasser Science 318 (5857), 1722-1722, 2007 | 165* | 2007 |
| Development of dendritic cell system L Wu, A Dakic Cell Mol Immunol 1 (2), 112-118, 2004 | 149 | 2004 |
| Development of dendritic cell system L Wu, A Dakic Cell Mol Immunol 1 (2), 112-118, 2004 | 149 | 2004 |
| Inactivation of PU. 1 in adult mice leads to the development of myeloid leukemia D Metcalf, A Dakic, S Mifsud, L Di Rago, L Wu, S Nutt Proceedings of the National Academy of Sciences 103 (5), 1486-1491, 2006 | 114 | 2006 |
| The development of functional B lymphocytes in conditional PU. 1 knock-out mice M Polli, A Dakic, A Light, L Wu, DM Tarlinton, SL Nutt Blood 106 (6), 2083-2090, 2005 | 104 | 2005 |
| Is PU. 1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? A Dakic, L Wu, SL Nutt Trends in immunology 28 (3), 108-114, 2007 | 87 | 2007 |
| Interconversion between tumorigenic and differentiated states in acute myeloid leukemia MD McKenzie, M Ghisi, EP Oxley, S Ngo, L Cimmino, C Esnault, R Liu, ... Cell stem cell 25 (2), 258-272. e9, 2019 | 84 | 2019 |
| Role of “cancer stem cells” and cell survival in tumor development and maintenance JM Adams, PN Kelly, A Dakic, S Carotta, SL Nutt, A Strasser Cold Spring Harbor symposia on quantitative biology 73, 451-459, 2008 | 36 | 2008 |
| Hemopoietic precursors and development of dendritic cell populations A Dakic, L Wu Leukemia & lymphoma 44 (9), 1469-1475, 2003 | 33 | 2003 |
| The Pu. 1 target gene Zbtb11 regulates neutrophil development through its integrase-like HHCC zinc finger MC Keightley, DP Carradice, JE Layton, L Pase, JY Bertrand, JG Wittig, ... Nature communications 8 (1), 14911, 2017 | 27 | 2017 |
| Excess granulopoiesis and subsequent acute myeloid leukemia induced by complete loss of PU. 1 in adult mice A Dakic, D Metcalf, L Di Rago, S Mifsud, L Wu, SL Nutt Tissue Antigens 66 (5), 388-389, 2005 | 1 | 2005 |
| Uncovering Key Downstream Effectors of PU. 1 Tumor Suppression in Acute Myeloid Leukemia M Ghisi, MD McKenzie, EP Oxley, E Simankowicz, C Liu, A Dakic, SL Nutt, ... Blood, The Journal of the American Society of Hematology 128 (22), 2698-2698, 2016 | | 2016 |
